Swiss pharma companies likely to follow PfizerU.S. price deal, says business lobby ReutersOctober 1, 2025 at 4:09 AM 0 U.S.
- - Swiss pharma companies likely to follow Pfizer-U.S. price deal, says business lobby
ReutersOctober 1, 2025 at 4:09 AM
0
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla, on the day he announces a deal with Pfizer to sell drugs at lower prices, in the Oval office of the White House in Washington, D.C., U.S., September 30, 2025. REUTERS/Ken Cedeno
GENEVA (Reuters) -Swiss pharma companies are likely to follow Pfizer's price deal with the U.S. following a demand from President Donald Trump's administration for lower drug prices, the head of a major Swiss chemical and pharmaceutical industry association said on Wednesday. Pfizer and Trump said on Tuesday they had agreed a deal in which the U.S. firm would lower prescription drug prices in the Medicaid program to match those it charges in other developed countries in exchange for tariff relief. Stephan Mumenthaler, director general of Scienceindustries - which represents around 250 Swiss chemical and pharmaceutical companies - told Reuters he expected announcements of "mini-deals" to come one by one in the coming days and weeks from Swiss and global pharmaceutical companies. "They are thinking in similar schemes...How can you omit the margins that middlemen are taking away so that you basically have a similar price than before, but the end consumer still gets a lower price," he said in a video call from Basel.
(Reporting by Olivia Le PoidevinEditing by Madeline Chambers)
Source: "AOL Money"
Source: ERIUS MAG
Full Article on Source: ERIUS MAG
#LALifestyle #USCelebrities